Personalis at Advances in Immuno-Oncology USA: OCT 8-9, 2019

Kedar Hastak, PhD
Field Application Scientist

Tuesday, OCT 8 | 2:50 PM – 3:20 PM

Advancing Precision Oncology Biomarker Discovery with a Multidimensional Immunogenomics Platform

• The search continues to ascertain biomarkers that will improve the selection of patients who will best respond to immunotherapies and help tailor these promising treatments
• The complexity of both the tumor and tumor microenvironment suggests a more comprehensive approach is needed for robust and accurate characterization of the cancer ecosystem
• The ImmunoID NeXT platform consolidates multiple biomarker assays into one with the ability to detect neoantigens, characterize the immune repertoire and identify novel biomarker signatures from a single sample
• We’ll discuss how to overcome barriers in translational research with this innovative assay design and optimized analytics for maximizing data generation for precision oncology